Denise Elliott, DPM
Foot & Ankle Surgery · Marrero, LANPI 1730152760
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Stryker at 34.5% of the total.
Across 181 payments — averaging $60.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Organogenesis Inc.$2K
- ALON Medical Technology$2K
- Medical Device Business Services, Inc.$1K
- International Life Sciences$611
- Amgen$207
- plus $2K from 30 others
What the payments were for
- Travel & lodging$3,59033%
- Food & beverage$5,93554%
- Education$1,48113%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 52 | $3,792 |
| Organogenesis Inc. | 42 | $1,544 |
| ALON Medical Technology | 3 | $1,502 |
| Medical Device Business Services, Inc. | 11 | $1,272 |
| International Life Sciences | 1 | $611 |
| Amgen | 2 | $207 |
| Cardiovascular Systems Inc. | 1 | $157 |
| Zimmer Biomet | 4 | $143 |
| GRT US Holding, Inc. | 3 | $134 |
| Johnson & Johnson | 2 | $132 |
| Sanara Medtech Inc. | 1 | $127 |
| Baxter Healthcare | 3 | $119 |
| Mimedx Group, Inc. | 5 | $113 |
| Bioventus LLC | 3 | $90 |
| AbbVie | 5 | $88 |
| Globus Medical | 2 | $79 |
| Biopoly LLC | 1 | $76 |
| Abbott | 3 | $75 |
| Smith+Nephew | 3 | $73 |
| Biocomposites Inc | 2 | $71 |
| Kerecis Limited | 2 | $68 |
| Averitas Pharma Inc. | 3 | $68 |
| Kowa Pharmaceuticals America, Inc. | 4 | $67 |
| KCI USA, Inc. | 4 | $66 |
| Medtronic | 2 | $53 |
| Nevro Corp. | 2 | $51 |
| Paratek Pharmaceuticals, Inc. | 3 | $50 |
| IBSA Pharma Inc. | 2 | $35 |
| Polarityte, Inc. | 2 | $29 |
| Tactile Systems Technology Inc | 2 | $24 |
| Reprise Biomedical, Inc. | 1 | $19 |
| Mckesson Patient Care Solutions Inc. | 1 | $18 |
| Merck | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $14 |
| Treace Medical Concepts, Inc. | 1 | $13 |
| Advanced Oxygen Therapy Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANCHORAGE$922
- MOTOBAND$562
- CITREFIX$548
- BIO4$368
- PROstep$179
- AXSOS$174
- Peripheral Orbital Atherectomy System$157
- CHARLOTTE$149
- CellerateRx$127
- KRYSTEXXA$125
- PuraPly$121
- PROSTEP MICA$115
- STAR$107
How this compares
$11,006 in reported general payments places this provider in the 85th percentile of 92 foot & ankle surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QutenzaCapsaicin/Skin Cleanser | 16 | $58,334 |
| JubliaEfinaconazole | 12 | $12,883 |
| SantylCollagenase Clostridium Hist. | 20 | $7,625 |
| Ammonium Lactate | 206 | $5,891 |
| Ciclopirox | 96 | $4,200 |
| Naftifine Hcl | 12 | $1,343 |
| Mupirocin | 87 | $774 |
| CiclopiroxCiclopirox Olamine | 21 | $593 |
| Gabapentin | 50 | $552 |
| Terbinafine Hcl | 34 | $528 |
| Pregabalin | 15 | $426 |
| Celecoxib | 23 | $334 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $238 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $235 |
| Allopurinol | 14 | $168 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GRT US Holding, Inc.Qutenza | $134 | $58,33416 claims |
| Smith+NephewSantyl | $73 | $7,62520 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 92 foot & ankle surgery providers in Louisiana.
Other foot & ankle surgery in Marrero
- Catherine HudsonMarrero$10K
- Brian BensonLeesville$278K
- Meredith WarnerBaton Rouge$232K
- Tyson GreenLake Charles$203K
- Bryon McKennaThibodaux$131K
- Mohamad IssaNew Orleans$24K
- Leon WatkinsMetairie$18K
- Phuoc BuiMinden$15K
- Henrique HilarioShreveport$14K
- Beau WillisMetairie$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.